細胞化驗分析市場規模、佔有率和成長分析（按產品、技術、應用、最終用戶和地區）- 產業預測 2025-2032

預計 2023 年全球細胞化驗分析市場規模將達到 172 億美元，並從 2024 年的 184.6 億美元成長到 2032 年的 324.3 億美元，預測期內（2025-2032 年）的複合年成長率為 7.3%。

COVID-19 疫情對全球研究格局產生了重大影響，促使人們迅速採用並研究開發有效的感染檢測方法。值得注意的是，診斷方面的創新已透過諸如獲得 FDA 緊急使用授權的 T-Detect COVID-19 T 細胞測試等測試得到體現。隨著感染疾病、癌症、自體免疫疾病和基因異常的增加，對藥物研發的需求以及對生物技術研究的需求增加，市場預計將大幅成長。基於細胞的藥物篩檢試驗對於選擇可行的候選藥物以及實現先導化合物分析、細胞訊號分析和毒性評估至關重要。 Annexin V-Cy3 細胞凋亡檢測套件就是一個例子，凸顯了這些檢測方法在推進治療方法研究和開發方面的多功能性和重要性。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 技術分析
• 專利分析
• 案例研究

細胞化驗分析市場規模（按類型和複合年成長率） (2025-2032)

• 市場概況
• 耗材
  • 試劑
  • 檢測試劑套件
  • 報導基因分析
  • 細胞生長化驗
  • 第二信使偵測
  • 細胞死亡化驗
  • 其他檢測試劑套件
  • 微孔盤
  • 細胞株
  • 永生化細胞株
  • 初代細胞系
  • 幹細胞株
  • 探針和標籤
  • 其他耗材
• 裝置
• 服務
• 軟體

細胞化驗分析市場規模（依技術分類）及複合年成長率（2025-2032）

• 市場概況
• 流式細胞技術
• 高通量篩檢
• 無標定檢測
• 其他技術

細胞化驗分析市場規模（依應用分類）及複合年成長率（2025-2032）

• 市場概況
• 藥物研發
  • 毒性研究
  • 藥物動力學研究
  • 動態研究
• 基礎研究
• 遺傳學研究
• 其他用途

細胞化驗分析市場規模（按最終用戶和複合年成長率） (2025-2032)

• 市場概況
• 製藥和生物技術公司
• 合約研究組織
• 學術研究所

細胞化驗分析市場規模（依地區分類）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Thermo Fisher Scientific, Inc.（United States）
• Promega Corporation（United States）
• Merck KGaA（Germany）
• PerkinElmer, Inc.（United States）
• Danaher Corporation（United States）
• Cell Signaling Technology, Inc.（United States）
• Bio-Rad Laboratories, Inc.（United States）
• Agilent Technologies, Inc.（United States）
• GE Healthcare（United Kingdom）
• Lonza Group Ltd.（Switzerland）

結論和建議

Global Cell-Based Assays Market size was valued at USD 17.2 billion in 2023 and is poised to grow from USD 18.46 billion in 2024 to USD 32.43 billion by 2032, growing at a CAGR of 7.3% during the forecast period (2025-2032).

The COVID-19 pandemic significantly impacted the global research landscape, prompting rapid adoption of efficient methodologies and the development of cell-based assays to detect infections. Notably, tests like the T-Detect COVID-19 T-cell test gained FDA Emergency Use Authorization, illustrating the innovation in diagnostics. As drug discovery demands rise alongside the need for biotechnology research due to increasing rates of infectious diseases, cancer, autoimmune disorders, and genetic anomalies, the market is positioned for substantial growth. Cell-based drug screening assays are crucial for selecting viable drug candidates, enabling lead profiling, cellular signaling analysis, and toxicity assessments. An example is the Annexin V-Cy3 apoptosis detection kit, highlighting the versatility and importance of these assays in advancing therapeutic research and development.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cell-Based Assays market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cell-Based Assays Market Segments Analysis

Global Cell-Based Assays Market is segmented by Offering, Technology, Application, End User and region. Based on Offering, the market is segmented into Consumables, Instruments, Services and Software. Based on Technology, the market is segmented into Flow Cytometry, High-Throughput Screening, Label-Free Detection and Other Technologies. Based on Application, the market is segmented into Drug Discovery, Basic Research, Genetic Studies and Other Applications. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Academic & Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cell-Based Assays Market

The rising incidence of chronic illnesses, including cancer, cardiovascular conditions, and neurodegenerative diseases, significantly drives the demand for sophisticated cell-based assays utilized in disease modeling and pharmaceutical testing. As healthcare professionals and researchers seek to innovate treatments and understand the complexities of these ailments, advanced assays become essential tools in their arsenal. These methodologies not only enhance the efficiency of drug development processes but also pave the way for more precise modeling of disease mechanisms. Consequently, this growing need for effective assessment techniques in the medical field is a major driver in the global cell-based assays market.

Restraints in the Global Cell-Based Assays Market

The Global Cell-Based Assays market faces significant restraints due to the resource-intensive nature of developing and conducting these assays. The associated costs for reagents, specialized equipment, and the need for skilled personnel can create substantial barriers, especially for smaller research organizations lacking the necessary financial and technical resources. This situation can hinder their ability to compete effectively in the market, limiting innovation and development opportunities. As a result, these factors may restrict the growth and accessibility of cell-based assays, potentially impacting the overall market dynamics and slowing advancements in related research fields.

Market Trends of the Global Cell-Based Assays Market

The Global Cell-Based Assays market is experiencing a notable trend towards the adoption of 3D cell culture models, driven by their enhanced ability to mimic in vivo physiological conditions. This transition is fostering more accurate drug screening and toxicity assessment, thereby increasing the effectiveness of preclinical testing. As research continues to emphasize the importance of biologically relevant platforms, the demand for advanced 3D cell culture technologies is likely to surge. This market shift reflects a broader commitment to improving drug development processes and ensuring better therapeutic outcomes, positioning 3D cell culture as a pivotal innovation in cell-based assay methodologies.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis
• Patent Analysis
• Case Studies
• Global Cell-Based Assays Market Size by Offering & CAGR (2025-2032)
• Market Overview
• Consumables
  • Reagents
  • Assay Kits
  • Reporter gene assays
  • Cell growth assays
  • Secondary messenger assays
  • Cell death assays
  • Other assay kits
  • Microplates
  • Cell Lines
  • Immortalized cell lines
  • Primary cell lines
  • Stem cell lines
  • Probes & Labels
  • Other Consumables
• Instruments
• Services
• Software

Global Cell-Based Assays Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Flow Cytometry
• High-Throughput Screening
• Label-Free Detection
• Other Technologies

Global Cell-Based Assays Market Size by Application & CAGR (2025-2032)

• Market Overview
• Drug Discovery
  • Toxicity Studies
  • Pharmacokinetic Studies
  • Pharmacodynamic Studies
• Basic Research
• Genetic Studies
• Other Applications

Global Cell-Based Assays Market Size by End User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations
• Academic & Research Institutes

Global Cell-Based Assays Market Size & CAGR (2025-2032)

• North America (Offering, Technology, Application, End User)
  • US
  • Canada
• Europe (Offering, Technology, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Offering, Technology, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Offering, Technology, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Offering, Technology, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Signaling Technology, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations